4 completed. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow ECG: new trials by email Literature Review of ECG trials Research Report on ECG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Codivir in Patients With COVID-19 Covidir injections, One Step Test, IgM and IgG dosage - Covid19 | Phase 1 | Completed | Code Pharma | 12 | 2021-03-29 | 2021-11-02 |
| Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG) Durvalumab, Vicineum, Acetaminophen - Urinary Bladder Neoplasms | Phase 1 | Completed | National Cancer Institute (NCI) | 15 | 2018-06-07 | 2026-10-27 |
| CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies CD19/CD22 CAR T-Cells, Fludarabine, Cyclophosphamide - Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, B Cell | Phase 1 | Completed | National Cancer Institute (NCI) | 54 | 2018-03-26 | 2025-06-04 |
| Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Rituximab, Conditioning chemotherapy, TMS - Myelodysplastic Syndromes, Hodgkin's Lymphoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 34 | 2015-09-24 | 2025-09-30 |
Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Burkitt Lymphoma (1) · COVID-19 (1) · Carcinoma in Situ (1) · Coronavirus Infections (1) · Hodgkin Disease (1) · Leukemia (1) · Leukemia, B-Cell (1) · Lymphoma, B-Cell (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1) · Philadelphia Chromosome (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Urinary Bladder Neoplasms (1)
National Cancer Institute (NCI) (3) · Code Pharma (1)
United States (3) · Brazil (1)
Alain Mina, M.D. (1) · Eynat Finkelshtein (1) · Nirali N Shah, M.D. (1) · Raju Chelluri, M.D. (1)
PMID 34687939, PMID 34889384, PMID 35605184, PMID 37486616, PMID 38376944, PMID 40331908, PMID 42248607